Bone MarrowBone Marrow CellsBone Marrow TransplantationKidney TransplantationTransplantation, HomologousTransplantsGraft RejectionGraft SurvivalBone Marrow DiseasesImmunosuppressive AgentsBone Marrow ExaminationTissue DonorsHematopoietic Stem CellsHeart TransplantationBone Marrow NeoplasmsTransplantationHematopoietic Stem Cell TransplantationLung TransplantationBone Marrow PurgingGraft vs Host DiseaseTransplantation, AutologousTime FactorsHematopoiesisTreatment OutcomeImmunosuppressionCyclosporineTissue and Organ ProcurementWhole-Body IrradiationColony-Forming Units AssayHistocompatibility TestingRetrospective StudiesAnemia, AplasticMice, Inbred C57BLTacrolimusLeukemiaLiving DonorsPostoperative ComplicationsCytomegalovirus InfectionsWaiting ListsCell DifferentiationTransplantation ImmunologyHistocompatibilityTransplantation ConditioningFetal Tissue TransplantationRadiation ChimeraTransplantation ChimeraStromal CellsCells, CulturedImmunocompromised HostFlow CytometryMycophenolic AcidRecurrenceAntigens, CD34Transplantation, IsogeneicSpleenCadaverFollow-Up StudiesLeukemia, Myeloid, AcuteGranulocytesHematologic NeoplasmsSurvival AnalysisKidney Failure, ChronicT-LymphocytesAcute DiseaseLiver FailureBiopsyMultiple MyelomaHLA AntigensSurvival RateAntilymphocyte SerumMyelodysplastic SyndromesBusulfanCyclophosphamideMice, Inbred BALB CRisk FactorsCell SeparationOpportunistic InfectionsMegakaryocytesTransplantation ToleranceGranulocyte Colony-Stimulating FactorCytomegalovirusHeart-Lung TransplantationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveStem Cell TransplantationBronchiolitis ObliteransPancytopeniaPrecursor Cell Lymphoblastic Leukemia-LymphomaPrognosisLeukemia, MyeloidLymphoproliferative DisordersBrain Tissue TransplantationTransplantation, HeterotopicAntibodies, MonoclonalImmunophenotypingLeukocyte CountBlood CellsProspective StudiesStem CellsHematologic DiseasesCombined Modality Therapy